Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1056 participants.
Also called NCT03242642
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,056 participants
- Sponsor
- Registry
-
NCT03242642
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada, Denmark
- Registry status
- Recruiting
Technical summary
Registry record NCT03242642. Non-randomized; no masking; primary purpose treatment. Start 2017-10-23 (actual); primary completion 2027-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- Acronym
- APOLLO
- Condition
- Mitral Valve Regurgitation
- Intervention (Device)
- Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR)
- Intervention (Device)
- Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR)
- Lead sponsor
- Medtronic Cardiovascular
Record details
- Record id
cardio:ct-nct03242642- Content hash
d012d623ba10b683ae7dc657b2e1892dfcd225b8f7651ebf6d1b0f378e4590d1